Portfolio Building Blocks World Pharma and Biotech Index ETF logo

Portfolio Building Blocks World Pharma and Biotech Index ETF (PBPH)

Market Closed
11 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
27. 97
-0.21
-0.753%
After Hours
$
29. 00
+1.03 +3.6907%
12.32M Market Cap
0.02% Div Yield
73,240 Volume
$ 28.18
Previous Close
Add Transaction
Day Range
27.97 28.29
Year Range
24.18 28.29
Want to track PBPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PBPH closed today lower at $27.97, a decrease of -0.753% from yesterday's close, completing a monthly increase of 2.6341% or $0.72. Over the past 12 months, PBPH stock gained 10.8074%.
PBPH pays dividends to its shareholders, with the most recent payment made on Dec 26, 2025. The next estimated payment will be in 7 months ago on Dec 26, 2025 for a total of $0.02288.
The stock of the company had never split.
The company's stock is traded on one exchange.

PBPH Chart

People also search for

Fractyl Health Inc.
$ 0.7
+3.9704%
TScan Therapeutics Inc.
$ 0.78
+1.2777%
GreenLight Biosciences Holdings
$ 0.3
-0.0334%
Bioharvest Sciences Inc.
$ 2.08
-1.1905%
Sify Technologies Limited Rights expiring 6/21/2024
$ 0.18
+2.0571%

Portfolio Building Blocks World Pharma and Biotech Index ETF (PBPH) FAQ

What is the stock price today?

The current price is $27.97.

On which exchange is it traded?

Portfolio Building Blocks World Pharma and Biotech Index ETF is listed on NASDAQ (NMS).

What is its stock symbol?

The ticker symbol is PBPH.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.02%.

What is its market cap?

As of today, the market cap is 12.32M.

Has Portfolio Building Blocks World Pharma and Biotech Index ETF ever had a stock split?

No, there has never been a stock split.

Portfolio Building Blocks World Pharma and Biotech Index ETF Profile

NASDAQ (NMS) Exchange
US Country

Overview

The Portfolio Building Block World Pharma and Biotech Index ETF is designed to provide investors with focused exposure to the dynamic and innovative sectors of pharmaceutical and biotechnology industries. These sectors play a critical role in healthcare advancements, with companies continuously pushing the boundaries of human therapeutics. The fund aims to mirror the performance of the BITA Global Pharma and Biotech Select Index, which specifically tracks firms in developed markets that earn a substantial share of their revenue from the entire spectrum of discovering, developing, and commercializing therapeutic solutions for human health.

Products and Services

  • World Pharma and Biotech Index ETF: This exchange-traded fund offers investors the opportunity to invest in a diversified portfolio of companies within the globally recognized pharmaceutical and biotechnology sectors. It aims to match the performance of the BITA Global Pharma and Biotech Select Index, providing a baseline for investors wanting exposure to these innovative markets.
  • Index Replication: The fund employs a systematic approach to replicate the performance of the BITA index, ensuring that the investment closely follows the movements and returns of leading pharmaceutical and biotech companies. This method allows investors to gain access to market trends and data without needing to conduct extensive research themselves.
  • Global Market Exposure: By focusing on companies in developed markets, this ETF grants investors a broad international reach, facilitating strategic investments in regions recognized for technological advancements and healthcare innovations. This global outlook helps to mitigate risk and capture growth opportunities across various markets.
  • Targeted Investment Strategy: The Portfolio Building Block ETF implements a targeted investment strategy that emphasizes firms generating significant revenue from human therapeutics. This focus allows investors to concentrate their capital on high-potential sectors within the health industry, driving better returns over time.
  • Risk Management: The fund is structured to leverage diversified exposure to pharmaceutical and biotech companies, effectively managing risk through a balanced approach. This can help in stabilizing returns amidst market volatility, providing investors with a more secure path towards their investment goals.

Contact Information

Address: 234 West Florida Street